2023-03-30T16:58:22+08:00 weekly 1.0 https://hr.prisysbiotech.com/ 2024-11-13T14:58:47+08:00 weekly 0.9 https://hr.prisysbiotech.com/animal-welfare 2024-11-13T14:58:49+08:00 weekly 0.9 https://hr.prisysbiotech.com/translational-research-center 2024-11-13T14:58:56+08:00 weekly 0.9 https://hr.prisysbiotech.com/metabolic-syndromes-research 2024-11-13T14:58:57+08:00 weekly 0.9 https://hr.prisysbiotech.com/ophthalmic-disease-research 2024-11-13T14:58:52+08:00 weekly 0.9 https://hr.prisysbiotech.com/hematological-disease-research 2024-11-13T14:58:56+08:00 weekly 0.9 https://hr.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-13T14:58:52+08:00 weekly 0.9 https://hr.prisysbiotech.com/inflammation-immunology-disorders 2024-11-13T14:58:57+08:00 weekly 0.9 https://hr.prisysbiotech.com/respiratory-disease-research 2023-04-01T03:49:38+08:00 weekly 0.9 https://hr.prisysbiotech.com/co-develop 2024-11-13T14:58:37+08:00 weekly 0.9 https://hr.prisysbiotech.com/download 2024-09-29T14:45:25+08:00 weekly 0.9 https://hr.prisysbiotech.com/nephrology 2024-09-29T14:23:03+08:00 weekly 0.9 https://hr.prisysbiotech.com/fibrosis 2024-11-13T14:58:45+08:00 weekly 0.9 https://hr.prisysbiotech.com/about-us 2024-11-13T14:58:49+08:00 weekly 0.9 https://hr.prisysbiotech.com/contact-us 2023-04-01T03:21:00+08:00 weekly 0.9 https://hr.prisysbiotech.com/newslist-1 2024-11-13T14:58:45+08:00 weekly 0.9 https://hr.prisysbiotech.com/products 2026-02-07T02:37:28+08:00 weekly 0.9 https://hr.prisysbiotech.com/blog/ 2023-04-01T03:05:50+08:00 weekly 0.9 https://hr.prisysbiotech.com/translation-research/ 2023-04-01T03:05:50+08:00 weekly 1.0 https://hr.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T03:05:51+08:00 weekly 0.9 https://hr.prisysbiotech.com/safety-evaluation/ 2023-04-01T03:05:51+08:00 weekly 0.9 https://hr.prisysbiotech.com/pk-pd-adme/ 2023-04-01T03:05:51+08:00 weekly 0.9 https://hr.prisysbiotech.com/biosafety-research/ 2024-04-08T21:02:45+08:00 weekly 0.9 https://hr.prisysbiotech.com/clearpoint/ 2023-04-01T03:21:15+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2024-11-13T14:58:47+08:00 weekly 0.8 https://hr.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2024-11-13T14:58:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2024-11-13T14:58:58+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2023-04-01T03:21:16+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-13T14:58:43+08:00 weekly 0.8 https://hr.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2023-04-01T03:21:21+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2024-11-13T14:58:46+08:00 weekly 0.8 https://hr.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2024-11-13T14:58:39+08:00 weekly 0.8 https://hr.prisysbiotech.com/translation-research/nhpresources.html 2023-04-01T03:21:18+08:00 weekly 0.8 https://hr.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2023-04-01T03:21:19+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2023-04-01T03:21:20+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2023-04-01T03:21:19+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2023-04-01T03:21:20+08:00 weekly 0.8 https://hr.prisysbiotech.com/pk-pd-adme/adme.html 2024-11-13T14:58:49+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2023-04-01T03:21:19+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2023-04-01T03:21:20+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2024-11-13T14:58:48+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2024-11-13T14:58:45+08:00 weekly 0.8 https://hr.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2023-04-01T03:21:22+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hr.prisysbiotech.com/safety-evaluation/toxicology.html 2024-11-13T14:58:45+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2023-04-01T03:21:19+08:00 weekly 0.8 https://hr.prisysbiotech.com/translation-research/translational-studies.html 2023-04-01T03:21:25+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2023-04-01T03:21:16+08:00 weekly 0.8 https://hr.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2024-11-13T14:58:49+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2024-11-13T14:58:47+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2024-11-13T14:58:46+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2024-11-13T14:58:49+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2024-11-13T14:58:48+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2024-11-13T14:58:44+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hr.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2024-11-13T14:58:41+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2024-11-13T14:58:56+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2024-11-13T14:58:44+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2024-11-13T14:58:48+08:00 weekly 0.8 https://hr.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-13T14:59:02+08:00 weekly 0.8 https://hr.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-13T14:58:46+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-13T14:59:00+08:00 weekly 0.8 https://hr.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-27T21:44:12+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-27T21:44:19+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-09-27T21:44:19+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-09-27T21:44:19+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-09-27T21:44:22+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-11-13T14:58:48+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-09-27T22:57:26+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-12-08T02:57:33+08:00 weekly 0.8 https://hr.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2024-12-08T07:50:07+08:00 weekly 0.8 https://hr.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2025-04-06T07:43:04+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-04-06T07:43:09+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-07-18T01:26:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-07-18T01:26:55+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-08-21T08:46:08+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-15T03:57:57+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-20T09:19:10+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-25T03:21:44+08:00 weekly 0.8 https://hr.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-10-01T20:19:19+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T18:26:42+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T20:09:33+08:00 weekly 0.8 https://hr.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2023-04-01T03:05:49+08:00 weekly 0.9 https://hr.prisysbiotech.com/newslist-714188-1 2023-04-01T03:05:49+08:00 weekly 0.9 https://hr.prisysbiotech.com/newslist-714189-1 2024-07-30T04:02:10+08:00 weekly 0.9 https://hr.prisysbiotech.com/newslist-818833-1 2023-04-01T03:21:41+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66124077.html 2023-04-01T03:21:15+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-sot2023-66124078.html 2023-04-01T03:21:16+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66124079.html 2023-04-01T03:21:19+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66124080.html 2023-04-01T03:21:14+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/meetprisys-sot2023-66124081.html 2023-04-01T03:21:16+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/gene-therapy-nhp-model-66124082.html 2023-04-01T03:21:17+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66124084.html 2023-04-01T03:21:19+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66124087.html 2023-04-01T03:21:18+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66124090.html 2023-04-01T03:21:23+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66124098.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/gene-therapy-toxicology-66273653.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67540621.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67540622.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67541581.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67542424.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67543393.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67543394.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67546232.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/world-parkinsons-disease-day-67547557.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68113928.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68113929.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68113930.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68113931.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68305950.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69010708.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69011037.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69011347.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69011350.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69011678.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69011679.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309292.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309353.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309354.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309401.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69654547.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69655437.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71067829.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/0-71067831.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71067832.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71067833.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71067834.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71067835.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321915.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321917.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321918.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321919.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321920.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72678331.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73021805.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73543335.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73543336.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74172037.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74675917.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74799302.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75167535.html 2024-11-13T14:58:39+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75167537.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76182417.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77062606.html 2024-11-13T14:58:38+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77718195.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77718196.html 2024-11-13T14:58:39+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79199854.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nhp-asthma-model-79199855.html 2024-11-13T14:58:41+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79199857.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79199859.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79199860.html 2024-11-13T14:58:40+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79419862.html 2024-11-13T14:58:40+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79419863.html 2024-11-13T14:58:37+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79420107.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79537678.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79537682.html 2024-11-13T14:58:35+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79537683.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79537687.html 2024-11-13T14:58:37+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/pk-strategies-of-pdc-79537689.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79537690.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79537691.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79537692.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79537693.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79537694.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79537695.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79537696.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79537697.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79537699.html 2024-11-13T14:58:47+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79537700.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79537701.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79537702.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79537703.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79537704.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79537705.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79537706.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79537707.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79537708.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79537709.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79537710.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79537711.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79537713.html 2024-11-13T14:58:41+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79537714.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79537715.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79537716.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79537717.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79537718.html 2024-11-13T14:58:40+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79537719.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79537720.html 2024-11-13T14:58:38+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/mrna-based-therapies-past-79537721.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79537722.html 2024-11-13T14:58:43+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79537723.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79537724.html 2024-11-13T14:58:41+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79537725.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79537726.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79537727.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79537728.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79537729.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79537730.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79537731.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/significance-principles-and-requirements-of-79537732.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/mrna-based-therapies-present-79538693.html 2024-08-07T08:44:39+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656489.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81159818.html 2024-11-13T14:58:44+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/convection-enhanced-delivery-81159819.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/animal-models-of-human-diseases-81159820.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/human-disease-animal-models-81159821.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/china-experimental-monkey-industry-81159822.html 2024-11-13T14:58:52+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81159823.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81159824.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81159825.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81159826.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/compartment-pk-model-81159828.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81159829.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81159830.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81159831.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82395262.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82719558.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82719559.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82719560.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82719562.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82719563.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82719565.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82719566.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82719568.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82719577.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83034314.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83039060.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83043738.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84034357.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84034358.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84034359.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84034360.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84034361.html 2025-01-17T19:05:31+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84034362.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84034368.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84034407.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84034951.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17245407385003008.html 2025-02-27T10:53:27+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17245407730672640.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17301644604351488.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17301644649833472.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/membranous-nephropathy-model-17301644650685440.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17301644657239040.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/animal-models-for-womens-health-17301644700509184.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17301644720579584.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17301644734030848.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17301644782183424.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17301644801516544.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17301644850373632.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17301644877112320.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17301644892136448.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17301644928885760.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17301645012542464.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17301645032956928.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17301645073179648.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17301645095625728.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17302651867620352.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17387440754828288.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17387440773440512.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17387440860226560.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17387440863454208.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17387440887768064.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17387440890192896.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/intracerebroventricular-icv-injection-17387440933561344.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17387440954614784.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17387441089815552.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17387441099449344.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17387441465582592.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17387524414465024.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17447079357654016.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17447079445062656.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17447079481402368.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17447079527638016.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17447079629628416.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17447079667950592.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17447079783064576.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17447080188847104.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/key-considerations-for-dosing-volume-17447118372398080.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17447118384587776.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17447118434182144.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17447118512808960.html 2025-08-21T08:45:36+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17495611323360256.html 2025-08-21T08:45:34+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nhp-copd-model-17495611393795072.html 2025-08-21T08:45:38+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17495611413455872.html 2025-08-21T08:45:43+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17495611446715392.html 2025-08-21T08:45:37+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17495611473617920.html 2025-08-21T08:45:44+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17495611489575936.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/brain-targeted-drug-delivery-17530746686350336.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/the-importance-of-administration-volume-17530746716955648.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530746732635136.html 2025-09-15T03:58:22+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530747009442816.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530747022599168.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530747028284416.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530747304043520.html 2025-09-20T09:19:17+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17538118219211776.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17554361248113665.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625071069258752.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625071101551616.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625071107400704.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625071167300608.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625071242732544.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625071314805760.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625071330157568.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625071344739328.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625071406982144.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625071544968192.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/nhp-renal-biopsy-17625071590286336.html 2025-12-25T18:26:40+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674563509445632.html 2025-12-25T18:26:38+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674563549144064.html 2025-12-25T18:27:03+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674563578831872.html 2025-12-25T18:26:48+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674563612419072.html 2025-12-25T18:26:47+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674563628016640.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674563682673664.html 2025-12-25T18:26:43+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674563698287616.html 2025-12-25T18:26:48+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674563779126272.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674563782697984.html 2026-01-29T20:09:29+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724203973305344.html 2026-01-29T20:09:28+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724203993244672.html 2026-01-29T20:09:28+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724204033991680.html 2026-01-29T20:09:42+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724204036662272.html 2026-01-29T20:09:43+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724204042314752.html 2026-01-29T20:09:40+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724204079260672.html 2026-01-29T20:09:33+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724204087583744.html 2026-01-29T20:09:44+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724204100543488.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724220623004672.html 2026-03-27T18:45:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724220653560832.html 2026-02-06T06:16:55+08:00 weekly 0.8 https://hr.prisysbiotech.com/blog/how-do-nhp-preclinical-studies-help-in-the-development-of-geriatric-drugs-2844578.html 2026-02-12T04:51:27+08:00 weekly 0.8 https://hr.prisysbiotech.com/blog/how-are-nhps-selected-for-a-study-2921463.html 2026-02-27T06:19:51+08:00 weekly 0.8 https://hr.prisysbiotech.com/blog/what-are-the-advantages-of-using-an-nhp-cro-3016066.html 2026-03-03T06:29:07+08:00 weekly 0.8 https://hr.prisysbiotech.com/blog/what-is-the-pharmacokinetic-profile-of-inhaled-drugs-3053038.html 2026-03-10T06:10:54+08:00 weekly 0.8 https://hr.prisysbiotech.com/blog/how-do-pd-drugs-influence-the-immune-cells-in-the-brain-in-pharmacology-3122306.html 2026-03-24T05:34:31+08:00 weekly 0.8 https://hr.prisysbiotech.com/blog/how-to-measure-the-infarct-volume-in-the-mcao-nhp-model-3321686.html